Study: ZW10 May Be A Key Drug Target for Cancer (G9183)

Target Name: ZW10

NCBI ID: G9183

ZW10

Study: ZW10 May Be A Key Drug Target for Cancer

ZW10 (KNTC1AP), a protein known as a potential drug target or biomarker, has been identified as a key regulator of the cell cycle and has been shown to play a role in various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

The ZW10 protein is a member of the T-cell homeostasis family, which is involved in regulating the immune system and maintaining the balance of different cell types within the body. The T-cell homeostasis family is composed of several proteins that work together to maintain the stability and integrity of the immune system, including T-cells, B-cells, and natural killer cells. ZW10 is a key regulator of the cell cycle, which is the process by which cells grow, divide, and replicate their genetic material.

The cell cycle is a complex process that involves the regulation of various proteins, including ZW10. It is the process by which cells prepare for cell division, and it is critical for the development and growth of new cells. ZW10 plays a key role in regulating the length of the cell cycle, as well as the entry and exit of cells from the cell cycle.

Research has shown that ZW10 is involved in the regulation of key cellular processes, including cell growth, apoptosis (programmed cell death), and inflammation. It has also been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of ZW10 are associated with the development of breast cancer, and that inhibiting the activity of ZW10 may be a promising strategy for cancer treatment.

In addition to its potential as a drug target, ZW10 also has potential as a biomarker. Its unique structure and function make it an attractive target for researchers to study and develop new diagnostic tools. For example, researchers have shown that ZW10 levels can be used as a biomarker for various diseases, including cancer, and that these levels can be measured and correlated with other clinical variables, such as disease stage and treatment effectiveness.

The discovery of ZW10 as a potential drug target has implications for the development of new treatments for a variety of diseases. By inhibiting the activity of ZW10, researchers may be able to slow down or even stop the growth of cancer cells, and potentially lead to a more effective treatment for this disease. Additionally, ZW10 may also be a useful biomarker for monitoring the effectiveness of cancer treatments and identifying potential drug targets for new treatments.

In conclusion, ZW10 (KNTC1AP) is a protein that is involved in the regulation of the cell cycle and has been shown to play a role in various diseases, including cancer. Its unique structure and function make it an attractive target for researchers to study and develop new treatments. Additionally, ZW10 may also be a useful biomarker for monitoring the effectiveness of cancer treatments and identifying potential drug targets for new treatments. Further research is needed to fully understand the role of ZW10 in the immune system and to develop new treatments based on its unique properties.

Protein Name: Zw10 Kinetochore Protein

Functions: Essential component of the mitotic checkpoint, which prevents cells from prematurely exiting mitosis. Required for the assembly of the dynein-dynactin and MAD1-MAD2 complexes onto kinetochores. Its function related to the spindle assembly machinery is proposed to depend on its association in the mitotic RZZ complex (PubMed:11590237, PubMed:15485811, PubMed:15824131). Involved in regulation of membrane traffic between the Golgi and the endoplasmic reticulum (ER); the function is proposed to depend on its association in the interphase NRZ complex which is believed to play a role in SNARE assembly at the ER (PubMed:15029241)

The "ZW10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZW10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets